InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Stejbach Mark, 董事. Officer active across 3 companies, notably Flexion Therapeutics Inc. In total, 5 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €23k. History available since 24 June 2021. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Mark Stejbach is a Board Member of Flexion Therapeutics Inc. and Indivior Pharmaceuticals, Inc. He brings expertise in corporate strategy and governance. His role on the boards allows him to actively participate in strategic decision-making for these companies. Through his experience, he helps guide growth initiatives and strengthen their market positions.